Astoria Strategic Wealth, Inc. recently announced the acquisition of new stake in Heart Test Laboratories Inc (NASDAQ:HSCS). The institutional investor has increased its shareholding in the Healthcare company by 246.09% to 81995.0 shares with purchase of 58303.0 shares. This fresh investment now brings its stake to 0.17% valued currently at $19843.0. In addition, Geode Capital Management LLC raised its holdings by 42316.0 to 42316.0 shares.
With over 28.71 million Heart Test Laboratories Inc (HSCS) shares trading Friday and a closing price of $0.17 on the day, the dollar volume was approximately $4.88 million. The shares have shown a negative half year performance of -81.02% and its price on 01/05/24 gained nearly 5.35%. Currently, there are 10.12M common shares owned by the public and among those 8.77M shares have been available to trade.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Fidelity Extended Market Index Fu owns 42316.0 shares of the company’s stock, all valued at over $10240.0. Vanguard Extended Market Index Fu sold 100.0 shares to see its total holdings shrink to 0.0 shares valued at over $0.0 and representing 0.00% of the shares outstanding.
However, the script later moved the day high at 0.1721, up 5.35%. The company’s stock has a 5-day price change of -4.89% and -55.99% over the past three months. HSCS shares are trading -2.11% year to date (YTD), with the 12-month market performance down to -79.34% lower. It has a 12-month low price of $0.14 and touched a high of $3.95 over the same period. HSCS has an average intraday trading volume of 8.74 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -0.15%, -13.62%, and -75.12% respectively.
Institutional ownership of Heart Test Laboratories Inc (NASDAQ: HSCS) shares accounts for 4.85% of the company’s 10.12M shares outstanding. Mutual fund holders own 1.03%, while other institutional holders and individual stakeholders account for 2.43% and 0.09% respectively.
It has a market capitalization of $1.88M and a beta (3y monthly) value of 3.62. The earnings-per-share (ttm) stands at -$0.61. Price movements for the stock have been influenced by the stock’s volatility, which stands at 9.07% over the week and 10.35% over the month.
Analysts forecast that Heart Test Laboratories Inc (HSCS) will achieve an EPS of -$0.06 for the current quarter, -$0.03 for the next quarter and -$0.14 for 2025. The lowest estimate earnings-per-share for the quarter is -$0.06 while analysts give the company a high EPS estimate of -$0.06. Comparatively, EPS for the current quarter was -$0.16 a year ago. Earnings per share for the fiscal year are expected to increase by 68.75%, and 44.00% over the next financial year.
If you are looking to buy this stock, then you may note that the average analyst recommendation by 1 brokerage firm advisors rate Heart Test Laboratories Inc (HSCS) as a “Strong Buy” at a consensus score of 1.00. Specifically, 1 Wall Street analysts polled rate the stock as a buy, while 0 of the 1 advise that investors “hold,” and 0 rated it as a “Sell.”
